Entity linked to ProMIS director buys 4,000 shares
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
ProMIS Neurosciences Inc. director Patrick D. Kirwin reported an open-market purchase of Common Shares through an associated professional corporation. The entity bought 4,000 shares at $11.33 per share, and now holds 4,653 shares indirectly. Kirwin also holds 5,135 shares directly and 305 shares indirectly through his spouse.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Purchase | Common Shares | 4,000 | $11.33 | $45K |
| Holding | Common Shares | -- | -- | -- |
| Holding | Common Shares | -- | -- | -- |
Key Figures
Key Terms
open-market purchase financial
indirect financial
transaction code financial
net-buy financial
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What insider transaction did ProMIS Neurosciences (PMN) report for Patrick D. Kirwin?
What are Patrick D. Kirwin’s direct and indirect ProMIS Neurosciences (PMN) holdings after the reported transactions?
How is indirect ownership disclosed for Patrick D. Kirwin in the ProMIS Neurosciences (PMN) Form 4?
AI-generated analysis. How Rhea-AI works. Not financial advice.